Cargando…

Vaccination against SARS-CoV-2 in a rural Ugandan population

Working within the context of a longstanding cohort in rural southwestern Uganda (the General Population Cohort), we collect health-related data in successive survey rounds from all residents of 25 adjacent villages on a biannual basis. Between January 2022 and July 2022, 2318 adult participants in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mugisha, Joseph, Mpairwe, Bernard, Kimono, Beatrice, Kaleebu, Pontiano, Newton, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Short communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404719/ https://www.ncbi.nlm.nih.gov/pubmed/37555080 http://dx.doi.org/10.1016/j.jvacx.2023.100355

Ejemplares similares

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda
por: Mugisha, Joseph, et al.
Publicado: (2023)

Alternate primers for whole-genome SARS-CoV-2 sequencing
por: Cotten, Matthew, et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers
por: Sansone, Emanuele, et al.
Publicado: (2021)

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
por: Namakoola, Ivan, et al.
Publicado: (2016)

The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden
por: Isitt, Catherine, et al.
Publicado: (2022)

SARS-CoV-2 transmission dynamics in the urban-rural interface
por: Polo, G., et al.
Publicado: (2022)

First case of postmortem study in a patient vaccinated against SARS-CoV-2
por: Hansen, Torsten, et al.
Publicado: (2021)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
por: Sugiyama, Kazuo, et al.
Publicado: (2022)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
por: King, William W., et al.
Publicado: (2021)

Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: A case report
por: Lazaro, Luciana G., et al.
Publicado: (2022)

Alterations in Laboratory Parameters Related to Disease Severity in Vaccinated Patients Against SARS-CoV-2
por: Lagadinou, Maria, et al.
Publicado: (2022)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States
por: Walker, Joseph, et al.
Publicado: (2022)

Evidence of antibodies against SARS‐CoV‐2 in wild mustelids from Brittany (France)
por: Davoust, Bernard, et al.
Publicado: (2022)

An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2
por: Cerino, Pellegrino, et al.
Publicado: (2021)

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
por: Hiroi, Satoshi, et al.
Publicado: (2023)

SARS-CoV-2-related mortality in a rural Latin American population
por: Del Brutto, Oscar H., et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Collaborated effort against SARS‐CoV‐2 outbreak in China
por: Yang, Qiwen, et al.
Publicado: (2020)

SARS-CoV-2 infection in fully vaccinated healthcare workers
por: Hernández Porto, Miriam, et al.
Publicado: (2022)

COVID-19 vaccines and decreased transmission of SARS-CoV-2
por: Vitiello, A., et al.
Publicado: (2021)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
por: Tomita, Yusuke, et al.
Publicado: (2020)

Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
por: Nantambi, Hellen, et al.
Publicado: (2023)

Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination
por: ARMONI-WEISS, Gil, et al.
Publicado: (2021)

Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial
por: Prentice, Sarah, et al.
Publicado: (2015)

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost
por: Kim, Woo Joo, et al.
Publicado: (2023)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Correction to: Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial
por: Prentice, Sarah, et al.
Publicado: (2020)

In silico analysis of protein/peptide-based inhalers against SARS-CoV-2
por: Salman, Saad, et al.
Publicado: (2020)

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021)

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
por: Bowes, Cynthia L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_evlnijrkuve1g9nmrjh71rjaf4